Who owns COCRYSTAL PHARMA INC?
- Ticker: COCP
- CUSIP Number: 19188j409
Tip: Access positions for across all investors
Analyze quarterly positions in Cocrystal Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Cocrystal Pharma stock
Who bought or sold COCRYSTAL PHARMA INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 276k | $386k | 0% | Mar 2024 |
|
BlackRock | 74k | $103k | 0% | Mar 2024 |
|
Geode Capital Management | 60k | $86k | 0% | Mar 2024 |
|
Morgan Stanley | 59k | $83k | 33% | Mar 2024 |
|
Susquehanna International | 52k | $75k | -28% | Mar 2024 |
|
UBS Group | 20k | $28k | 12031% | Mar 2024 |
|
Northern Trust | 12k | $17k | 0% | Mar 2024 |
|
Bank of America Corporation | 9.0k | $13k | 0% | Mar 2024 |
|
Tower Research Capital | 7.5k | $10k | 123% | Mar 2024 |
|
Jpmorgan Chase & Co | 543.00 | $776.001300 | -75% | Mar 2024 |
|
Vima | 231.00 | $458.396400 | 3% | Mar 2024 |
|
Wells Fargo & Company | 93.00 | $130.702200 | 1% | Mar 2024 |
|
NVWM | 84.00 | $118.003200 | 0% | Mar 2024 |
|
Royal Bank of Canada | 51.00 | $0 | 467% | Mar 2024 |
|
Who sold out of Cocrystal Pharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
FMR | Sep 2023 | 187.00 | $350.007900 |